• Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of September 23, 2024

  • Sep 26 2024
  • Duración: 12 m
  • Podcast

Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of September 23, 2024

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this edition, blue-collar workers more likely to miss work or quit due to psoriatic arthritis, infliximab biosimilar increase after release of a third option and more.

    Read the full coverage here:

    Blue-collar workers more likely to miss work, quit due to psoriatic arthritis

    Infliximab biosimilar uptake rapidly increased only after release of a third option

    National Psoriasis Foundation to honor leaders at 2025 Commit to Cure Gala

    Safety checklist compiles clinically important DMARD warnings in one place

    Guselkumab demonstrates long-term efficacy, safety in psoriasis

    References:

    Colla N, et al. Clin Rheumatol. 2024;doi:10.1007/s10067-024-07077-1.

    Gargiulo L, et al. J Drugs Dermatol. 2024;doi:10.36849/JDD.7486R1.

    Press Release

    Roberts ET, et al. Arthritis Rheumatol. 2024;doi:10.1002/art.42963.

    Skaarup L, et al. Drug Saf. 2024;doi:10.1007/s40264-024-01461-1.
    Más Menos
Más Menos

Lo que los oyentes dicen sobre Rheumatology/Psoriatic Arthritis Edition: Top Headlines for Week of September 23, 2024

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles